RPS21: A Potential Drug Target for Cancer (G6227)

Target Name: RPS21

NCBI ID: G6227

RPS21

RPS21: A Potential Drug Target for Cancer

Ribosomal protein S21 (RPS21) is a protein that is synthesized in the Ribosome, which is a complex organelles that is responsible for the translation of DNA into proteins. RPS21 is a 21-kDa protein that is expressed in most organisms, including humans. It plays a critical role in the regulation of gene expression and cell signaling.

One of the unique features of RPS21 is its ability to interact with small molecules, including drugs. This interaction makes RPS21 an attractive drug target and a potential biomarker for various diseases.

RPS21 functions as a protein kinase, which means it can phosphorylate other proteins. This process regulates various cellular processes, including cell signaling, DNA replication, and protein synthesis. RPS21 can phosphorylate a variety of proteins, including some important signal transduction molecules, such as kinases and phosphorylases.

Phosphorylation of RPS21 can be regulated in multiple ways. On the one hand, its function can be controlled by regulating the phosphorylation of RPS21 itself. On the other hand, its function can be affected by modulating the interaction of RPS21. For example, RPS21 can interact with some drugs, which can affect the phosphorylation of RPS21 and thus affect its function.

Phosphorylation of RPS21 also plays an important role in tumorigenesis and development. Studies have shown that the phosphorylation status of RPS21 is positively correlated with tumor invasion and metastasis capabilities. In addition, the phosphorylation status of RPS21 is also positively correlated with tumor chemotherapy sensitivity. These findings provide an important theoretical basis for studying the role of RPS21 in tumor treatment.

In addition to its role in tumorigenesis and progression, RPS21 also plays an important role in cell signaling. RPS21 can phosphorylate many important signal transduction molecules, such as FAK, PTEN and CREB. Phosphorylation of these signal transduction molecules can regulate a variety of signaling pathways within cells, thereby affecting cell growth, proliferation, and differentiation.

In addition, RPS21 can also regulate metabolic processes within cells. RPS21 can phosphorylate a variety of metabolic enzymes, such as pyruvate kinase and glucokinase. Phosphorylation of these metabolic enzymes can affect intracellular metabolic pathways, thereby affecting cellular energy metabolism and metabolites.

In drug research and development, RPS21 has received widespread attention as a potential drug target. Many studies have shown that RPS21 can be inhibited by a variety of drugs, including inhibitors of RPS21 phosphorylation, inhibitors of RPS21-drug interactions, and drug-binding antibodies. These drugs can significantly inhibit the function of RPS21, thereby affecting its cell signaling and metabolic pathways.

In addition, some studies have also shown that the phosphorylation status of RPS21 can serve as an important biomarker in tumor treatment. For example, some studies have shown that the phosphorylation status of RPS21 can be used to predict tumor invasion and metastasis capabilities, as well as assess tumor chemotherapy sensitivity. These findings provide important experimental basis for studying the role of RPS21 in tumor treatment.

In summary, RPS21 is a protein that plays an important role in cell signaling and metabolic pathways. Its phosphorylation status can be used as a drug target and an important biomarker in tumor treatment. With the continuous deepening of drug research and development, RPS21 is expected to become an important target for the treatment of cancer in the future.

Protein Name: Ribosomal Protein S21

Functions: Component of the small ribosomal subunit (PubMed:23636399, PubMed:25901680, PubMed:25957688). The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell (PubMed:23636399, PubMed:25901680, PubMed:25957688)

The "RPS21 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPS21 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets